ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,928.74
-0.71%
Dow Jones
42,706.45
-0.66%
US Dollar vs MXN
20.59227
1.32%
Brent Oil
74.255
0.86%
Bitcoin
94,492.00
1.04%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Avid Bioservices Inc (CDMOP) Cotización

Avid Bioservices Inc

Avid Bioservices Inc (CDMOP)

NASDAQ
25.06
0.00
( 0.00% )
Actualizado: 18:00:00
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
25.06
Postura de Compra
18.00
Postura de Venta
26.00
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
1.591B
Precio Anterior
25.06
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
63,480,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-5.56
Beneficio por acción (BPA)
-2.22
turnover
139.91M
Beneficio neto
-140.75M

Acerca de Avid Bioservices Inc

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP cli... Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.peregrineinc.com
Sede
Wilmington, Delaware, USA
Fundado
-

CDMOP Últimas noticias

Más noticias

Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand

TUSTIN, Calif., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization...

4 horas hace
GlobeNewswire Inc.

Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction

TUSTIN, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization...

18 Diciembre 2024
GlobeNewswire Inc.

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024

TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

10 Diciembre 2024
GlobeNewswire Inc.

Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction

TUSTIN, Calif. and LONDON and BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and...

06 Noviembre 2024
GlobeNewswire Inc.

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

12 Septiembre 2024
GlobeNewswire Inc.

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...

09 Septiembre 2024
GlobeNewswire Inc.

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

03 Septiembre 2024
GlobeNewswire Inc.

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell...

02 Julio 2024
GlobeNewswire Inc.

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

01 Julio 2024
GlobeNewswire Inc.

Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance

TUSTIN, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

23 Mayo 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

CDMOP - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Avid Bioservices?
El precio actual de las acciones de Avid Bioservices es US$ 25.06
¿Cuántas acciones de Avid Bioservices están en circulación?
Avid Bioservices tiene 63,480,000 acciones en circulación
¿Cuál es la capitalización de mercado de Avid Bioservices?
La capitalización de mercado de Avid Bioservices es USD 1.59B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Avid Bioservices?
Avid Bioservices ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Avid Bioservices?
El ratio precio/beneficio de Avid Bioservices es -5.56
¿Cuál es el ratio de efectivo a ventas de Avid Bioservices?
El ratio de efectivo a ventas de Avid Bioservices es 5.59
¿Cuál es la moneda de reporte de Avid Bioservices?
Avid Bioservices presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Avid Bioservices?
El último ingresos anual de Avid Bioservices es USD 139.91M
¿Cuál es el último beneficio anual de Avid Bioservices?
El último beneficio anual de Avid Bioservices es USD -140.75M
¿Cuál es la dirección registrada de Avid Bioservices?
La dirección registrada de Avid Bioservices es 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Avid Bioservices?
La dirección del sitio web de Avid Bioservices es www.peregrineinc.com
¿En qué sector industrial opera Avid Bioservices?
Avid Bioservices opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
NXUNXU Inc
US$ 1.74
(614.87%)
491.21M
WATTEnergous Corporation
US$ 1.425
(246.55%)
170.53M
INTZIntrusion Inc
US$ 5.1435
(138.13%)
119.31M
SMXSMX Security Matters Public Company
US$ 0.7833
(121.52%)
239.02M
CYNCYNGN Inc
US$ 1.285
(104.65%)
66.84M
ABPAbpro Holdings Inc
US$ 2.17
(-51.67%)
1.58M
TRAWTraws Pharma Inc
US$ 8.19
(-38.97%)
930.34k
SHOTWSafety Shot Inc
US$ 0.13
(-27.90%)
1.25k
LITMSnow Lake Resources Ltd
US$ 1.155
(-27.81%)
46.42M
DOMHDominari Holdings Inc
US$ 0.843
(-26.70%)
134.38k
NXUNXU Inc
US$ 1.74
(614.87%)
494.59M
VINCVincerx Inc
US$ 0.3439
(77.27%)
312.66M
SMXSMX Security Matters Public Company
US$ 0.7833
(121.52%)
239.64M
XTIAXTI Aerospace Inc
US$ 0.04
(1.27%)
200.6M
WATTEnergous Corporation
US$ 1.425
(246.55%)
171.27M

Discusión

Ver feed completo
JusDePomme JusDePomme 29 segundos hace
AFUU bottom chart appear
WhAtEvA1 WhAtEvA1 36 segundos hace
If events continue as it currently appears, down the road, we may be in for early trial data from India for the multi- indications trial well before same trial begins in the US. Your inkling is likely right about the Doc.
RDGL
tw0122 tw0122 48 segundos hace
BLBX missed it + 80%
ShawnP123 ShawnP123 1 minuto hace
I still believe 6 months. Not till Q1 to Q2. The Q4 report in Feb if above what I think it will be could change things but not counting on it. I think investors will need to great Q's. I still don't believe $168 realistic for 2025.
NVDA
JRoon71 JRoon71 1 minuto hace
RMB, I think it's a tough question to answer - I don't know how many different insurers Amarin negotiates with (as well as PBM's on behalf of insurers). And we also don't know what the contract terms are. From what I recall, some contracts are annual, some are multi-year, etc. So it's likely that pr
PBM
Monksdream Monksdream 2 minutos hace
AMPX, battery play

https://investorshub.advfn.com/uimage/uploads/2024/12/30/bliymIMG_4341.gif
AMPX
dstock07734 dstock07734 2 minutos hace
Did I tell you my investment decision is data-driven not BS-driven? You didn't search all latest 10Qs from Merck, did you? Here is your homework. Finish it and come back to talk.

10K 2020
https://www.sec.gov/ix?doc=/Archives/edgar/data/310158/000031015821000004/mrk-20201231.ht
NWBO
JFBroderick JFBroderick 2 minutos hace
Report of record Q4 in conjunction with update on dilution could send this into the stratosphere. 
ASII
OldAIMGuy OldAIMGuy 2 minutos hace
I was talking with a friend recently and we were discussing whether CASH is a naughty Anglo-Saxon Four Letter Word! During 2024 it seems that sidelining cash was missing an opportunity. However, that's only if we consider Cash's value vs turning it into risk.

I suggested that for any
PennyMillions852 PennyMillions852 2 minutos hace
Wow…right back down with the ask stacked with 2.6 milly at .0042….WTF?
IGPK
BeardOfWallSt BeardOfWallSt 2 minutos hace
Dips don't last long 
HLLK
NASDAQ2020 NASDAQ2020 2 minutos hace
What will $400 million dollars more in revenue from Vyvanse do for the SP and Buyout price ?
THX in Advance
ELTP
StockItOut StockItOut 2 minutos hace
Have you saved your same 'save the message' from three years ago?

You're a bullshitter!

You're like Keith Duffy. SmartyPants2, you rinse repeat empty claims.
XERI
knrorrel knrorrel 3 minutos hace
$OONEF beast mode

OONEF
Mark Mark 3 minutos hace
$EYEN .105
EYEN
vlispxpert vlispxpert 3 minutos hace
AMPX back in, possible monster...jmho
AMPX
LowFloatLopes LowFloatLopes 3 minutos hace
I remember seeing $.15 last week lol
OONEF
LowFloatLopes LowFloatLopes 4 minutos hace
Understatement lol 
OONEF
longago longago 4 minutos hace
Paying cash for an asset does not affect the P&L.

I suspect they did a poor job of estimating the cost of a construction project and did progress billing along the way at key completion targets. When the job was completed they had to book a loss on the project.

Remember
RJDG
Viking61 Viking61 4 minutos hace
Freddie has half of the shares outstanding, won in the 8-0 jury verdict, earns more per share and should be 10% higher than Fannie.
FNMA
LowFloatLopes LowFloatLopes 4 minutos hace
I already have some ...HOLO gonna break hard too 
HOLO
knrorrel knrorrel 4 minutos hace
beast mode
OONEF
johnydollar johnydollar 4 minutos hace
So are you saying 🤔 you already won......

You are just here celebrating your victory......

Most people i know they are happy when they have won.......

They don't act like sore loser.......

Go ahead on a private island 🏝 cele
DBMM
Bull_Dolphin Bull_Dolphin 4 minutos hace
The moon isn't the only thing that affects tides, the sun pulls too. So when the earth is in its winter tilt, there's more pull on the southern hemisphere. In the summer there's a lot more water up here.

Su Consulta Reciente

NASDAQ
CDMOP
Avid Bioservices
ASX
IB8
iBosses
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados